NCT03956953View on ClinicalTrials.gov

Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

September 25, 2019

Study Completion Date

September 25, 2019

Conditions
Autoimmune Diseases
Interventions
DRUG

BMS-986165

Dose 1 or Dose 2 on Day 1, and from Days 5-19'

OTHER

Placebo

Placebo matching Dose 1 or Dose 2 on Day 1, and from Days 5-19

Trial Locations (1)

100029

Local Institution, Beijing

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03956953 - Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter